NDC Package 17228-0777-9 Ticagrelor

Tablet, Film Coated - View Billable Units, 11-Digit Format, RxNorm

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
17228-0777-9
Package Description:
25000 TABLET, FILM COATED in 1 DRUM
Product Code:
Non-Proprietary Name:
Ticagrelor
Substance Name:
Ticagrelor
Usage Information:
Ticagrelor is used along with low-dose aspirin to help prevent heart attack and stroke in people with heart problems (such as unstable angina, previous heart attack). It may also prevent blood clots after certain heart surgeries (such as stent placement). Ticagrelor works by blocking platelets from sticking together and prevents them from forming harmful clots. It is an antiplatelet drug. It keeps blood flowing smoothly in your body.
11-Digit NDC Billing Format:
17228077709
Product Type:
Drug For Further Processing
Labeler Name:
Astrazeneca Ab
Dosage Form:
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
07-20-2011
Listing Expiration Date:
12-31-2024
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Other Product Packages

The following packages are also available for this product:

NDC Package CodePackage Description
17228-0777-025000 TABLET, FILM COATED in 1 DRUM

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 17228-0777-9?

The NDC Packaged Code 17228-0777-9 is assigned to an UNFINISHED drug package of 25000 tablet, film coated in 1 drum of Ticagrelor, drug for further processing labeled by Astrazeneca Ab. The product's dosage form is tablet, film coated and is administered via form.

Is NDC 17228-0777 included in the NDC Directory?

Yes, Ticagrelor is an UNFINISHED PRODUCT with code 17228-0777 that is active and included in the NDC Directory. The product was first marketed by Astrazeneca Ab on July 20, 2011 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 17228-0777-9?

The 11-digit format is 17228077709. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-117228-0777-95-4-217228-0777-09